These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22361135)

  • 1. Indolyl and dihydroindolyl N-glycinamides as potent and in vivo active NPY5 antagonists.
    Wu L; Lu K; Packiarajan M; Jubian V; Chandrasena G; Wolinsky TC; Walker MW
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2167-71. PubMed ID: 22361135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Heteroaryl glycinamides and glycinamines as potent NPY5 antagonists.
    Wu L; Lu K; Desai M; Packiarajan M; Joshi A; Marzabadi MR; Jubian V; Andersen K; Chandrasena G; Boyle NJ; Walker MW
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5573-6. PubMed ID: 21782430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterization of 3-[2-[6-(2-tert-butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl]benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist.
    Elliott RL; Oliver RM; Hammond M; Patterson TA; She L; Hargrove DM; Martin KA; Maurer TS; Kalvass JC; Morgan BP; DaSilva-Jardine PA; Stevenson RW; Mack CM; Cassella JV
    J Med Chem; 2003 Feb; 46(5):670-3. PubMed ID: 12593645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design.
    Guba W; Neidhart W; Nettekoven M
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1599-603. PubMed ID: 15745805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel orally active NPY Y5 receptor antagonists: Synthesis and structure-activity relationship of spiroindoline class compounds.
    Sakamoto T; Moriya M; Tsuge H; Takahashi T; Haga Y; Nonoshita K; Okamoto O; Takahashi H; Sakuraba A; Hirohashi T; Shibata T; Kanno T; Ito J; Iwaasa H; Gomori A; Ishihara A; Fukuroda T; Kanatani A; Fukami T
    Bioorg Med Chem; 2009 Jul; 17(14):5015-26. PubMed ID: 19525116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists.
    Hipskind PA; Lobb KL; Nixon JA; Britton TC; Bruns RF; Catlow J; Dieckman-McGinty DK; Gackenheimer SL; Gitter BD; Iyengar S; Schober DA; Simmons RM; Swanson S; Zarrinmayeh H; Zimmerman DM; Gehlert DR
    J Med Chem; 1997 Nov; 40(23):3712-4. PubMed ID: 9371234
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay.
    Beauverger P; Rodriguez M; Nicolas JP; Audinot V; Lamamy V; Dromaint S; Nagel N; Macia C; Léopold O; Galizzi JP; Caignard DH; Aldana I; Monge A; Chomarat P; Boutin JA
    Cell Signal; 2005 Apr; 17(4):489-96. PubMed ID: 15601626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder.
    Packiarajan M; Marzabadi MR; Desai M; Lu Y; Noble SA; Wong WC; Jubian V; Chandrasena G; Wolinsky TD; Zhong H; Walker MW; Wiborg O; Andersen K
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5436-41. PubMed ID: 21782428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of the potent, orally available, brain-penetrable arylpyrazole class of neuropeptide Y5 receptor antagonists.
    Sato N; Takahashi T; Shibata T; Haga Y; Sakuraba A; Hirose M; Sato M; Nonoshita K; Koike Y; Kitazawa H; Fujino N; Ishii Y; Ishihara A; Kanatani A; Fukami T
    J Med Chem; 2003 Feb; 46(5):666-9. PubMed ID: 12593644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of selective neuropeptide Y2 peptide agonists.
    DeCarr LB; Buckholz TM; Coish PD; Fathi Z; Fisk SE; Mays MR; O'Connor SJ; Lumb KJ
    Bioorg Med Chem Lett; 2007 Jan; 17(2):538-41. PubMed ID: 17055726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of substituted 2-cyclohexyl-4-phenyl-1H-imidazoles: potent and selective neuropeptide Y Y5-receptor antagonists.
    Blum CA; Zheng X; De Lombaert S
    J Med Chem; 2004 Apr; 47(9):2318-25. PubMed ID: 15084130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization.
    Bignon E; Alonso R; Arnone M; Boigegrain R; Brodin R; Gueudet C; Héaulme M; Keane P; Landi M; Molimard JC; Olliero D; Poncelet M; Seban E; Simiand J; Soubrié P; Pascal M; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1999 May; 289(2):752-61. PubMed ID: 10215649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azabicyclo[3.1.0]hexane-1-carbohydrazides as potent and selective GHSR1a ligands presenting a specific in vivo behavior.
    Sabbatini FM; Melotto S; Bernasconi G; Bromidge SM; D'Adamo L; Rinaldi M; Savoia C; Mundi C; Di Francesco C; Zonzini L; Costantini VJ; Perini B; Valerio E; Pozzan A; Perdonà E; Visentini F; Corsi M; Di Fabio R
    ChemMedChem; 2011 Nov; 6(11):1981-5. PubMed ID: 21834097
    [No Abstract]   [Full Text] [Related]  

  • 15. A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice.
    DeCarr LB; Buckholz TM; Milardo LF; Mays MR; Ortiz A; Lumb KJ
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1916-9. PubMed ID: 17292607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New indole amide derivatives as potent CRTH2 receptor antagonists.
    Zaghdane H; Boyd M; Colucci J; Simard D; Berthelette C; Leblanc Y; Wang Z; Houle R; Lévesque JF; Molinaro C; Hamel M; Stocco R; Sawyer N; Sillaots S; Gervais F; Gallant M
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3471-4. PubMed ID: 21515053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists.
    Gillman KW; Higgins MA; Poindexter GS; Browning M; Clarke WJ; Flowers S; Grace JE; Hogan JB; McGovern RT; Iben LG; Mattson GK; Ortiz A; Rassnick S; Russell JW; Antal-Zimanyi I
    Bioorg Med Chem; 2006 Aug; 14(16):5517-26. PubMed ID: 16697206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
    Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
    Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists.
    Lunniss GE; Barnes AA; Barton N; Biagetti M; Bianchi F; Blowers SM; Caberlotto LL; Emmons A; Holmes IP; Montanari D; Norris R; Puckey GV; Walters DJ; Watson SP; Willis J
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7341-4. PubMed ID: 21074426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and SAR of a novel series of benzimidazoles as potent NPY Y5 antagonists.
    Pizzi DA; Leslie CP; Mazzali A; Seri C; Biagetti M; Bentley J; Genski T; Di Fabio R; Contini S; Sabbatini FM; Zonzini L; Caberlotto L
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7120-3. PubMed ID: 20951033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.